PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

COVID-19 and Pharma’s In-Person Sales Model

Lean Thinking in Life Sciences: A Case for Enabling People

Feds Target Biosimilar Anticompetitive Practices

TOP STORY
COVID-19 Upends Business-as-usual Research and Regulatory Practice
The biomedical research community is rushing to develop treatments and preventives to halt the spread and severity of the COVID-19 virus. Jill Wechsler reports
/Read more/
Audio
Combating Coronavirus: The Pharm Exec Podcast
Dr. Eric von Hofe, Chief Scientific Officer at NuGenerex Immuno-Oncology, talks about the outbreak of coronavirus around the world and how biotechs and pharma are jumping in to help find a solution
/Click here to listen/

Advertisement
Minimizing the Negative Impact of Sales Rep Vacancies
The impact of vacant sales territories on overall brand performance is often underestimated within pharma and biotech companies. There are varying causes of vacancies, including rep promotions and transfers, resignations, terminations, and organizational restructuring. These vacancies have significant impact on pharma and biotech brands.
Read the Article
INTERVIEWS
Tackling Drug Shortages through Robust Supply Chains
MilliporeSigma's Robert McGuirk on the role of supply chain robustness in helping to mitigate the risk of drug shortages
/Read more/
 
Tending the Digital Garden: Francesca Wuttke, Almirall
Almirall’s Francesca Wuttke talks about her first year as the company’s Chief Digital Officer and the new initiatives she is overseeing, such as the Digital Garden
/Read more/
 
Strategy
How UCB Transformed into a More Agile, Data-Driven Organization
Anita Moser, Michael Davis, Dharmendra Sahay outline UCB's measured approach to scaling its AI capabilities
/Read more/
Calendar
Barcelona, Spain
/ April 20–22, 2020: Digital Health for Pharma /
Philadelphia, PA.
/ April 22–24: 9th Digital Marketing for Medical Devices West /
Burlingame, CA
/ April 29–May 1, 2020: Pharmaceutical Compliance Congress (PCC) 2020 /
Washington, D.C.
/ June 2: PING Conference 2020 /
Hatfield, UK
/ June 14–18, 2020: DIA 2020 Global Annual Meeting /
Washington, D.C.
/ June 15–17: BePharma 2020 /
Mexico City, Mexico
/ June 16–17: Financial Strategies and Accounting /
San Francisco, CA
/ June 16–18: Patient Support Services Congress /
Philadelphia, PA
Industry update
//Private biotechnology company Memgen (Houston, TX) appointed Gregory B. Brown, M.D., as Chief Executive Officer. The company also announced that Robert Coates, Ph.D., founder and prior Chief Executive Officer, will become Executive Chairman. //Ashfield (Fort Washington, PA) part of UDG Healthcare plc, appointed Carey Galvin as Global Head of Quality and Compliance for Ashfield Commercial, Patient Solutions and Medical Affairs. //Latham BioPharm Group (Cambridge, MA) a provider of life science consulting services, announced the recent addition of Dr. Thijs Beuming to the team to lead In Silico Drug Discovery services. //Health and wellness marketing agency Fingerpaint announced that Michelle Petroff was promoted to lead the Conshohocken, PA, office.
Advertisement
Education: The Creative Differentiator
How can we turn medical science into creative educational expressions? Consider a women’s health brand that invited prescribers to find education in a simulated, intimate bedroom setting (which received enthusiastic engagement from leading KOLs), or a migraine therapy that presented professionals with a crime scene–type experience, providing the “body of evidence” to educate about migraine’s effects throughout the body.
Read the Article

 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com